Immucor and Sirona Genomics announced this week that they have received the CE mark for their Mia Fora NGS system for HLA typing. The system is a high-resolution HLA typing solution for accurate cover [...]
QB3@953, a biotech incubator, has been so successful that many of the startups housed there are searching for larger laboratories in Southside San Francisco. But their moves have been stymied by high [...]
Pfizer ($PFE) announced earlier this month that it is financing the drug discovery efforts of four early-stage companies to the tune of a combined $46 million, including 4D Molecular Therapeutics, the [...]
NEW YORK (GenomeWeb) – Amarantus Bioscience Holdings announced today that it has signed a letter of intent to merge its Amarantus Diagnostics subsidiary with Avant Diagnostics. Upon the close of the [...]
LONDON—A promising new avenue in Alzheimer’s research that focuses on the eradication of brain plaque by the immune system has become the first investment for a $100 million fund dedicated to deliver [...]
Alector LLC, a biotech company pioneering the discovery and development of first-in-class, immuno-modulatory therapies for Alzheimer’s disease and other neurodegenerative disorders, today announced t [...]
for Cardiac Gene Therapy Vector Discovery and Development 4D Molecular Therapeutics (4DMT), a leader in Adeno-Associated Virus (AAV) gene therapy vector discovery and product development, today annou [...]
The notion of small molecules that detect dozens of cancers may sound like something out of a science-fiction novel. But for Christodoulou and her peers at Miroculus, it's more akin to a modern-day re [...]
Chemical engineer David Whitlock has made a splash in the media as of late, due to his lack of “splash”—as in the man hasn’t bathed in 12 years. The reason behind such a choice? David is working to d [...]
With FDA calling for non-invasive new tracking systems to accompany cell therapies, Bell Biosystems Inc. wants its Magnelle trackers to become the technology of choice. While the magnetic organelles' [...]